Variant report

Variant	esv3374812
Chromosome Location	chr21:46727924-46732222
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:413)
CpG islands
(count:0)
Chromatin interactive
region (count:23)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:413 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr21:46728394-46728753	HepG2	liver:	n/a	n/a
2	ATF3	chr21:46729029-46729254	K562	blood:	n/a	n/a
3	BCL3	chr21:46729827-46730374	GM12878	blood:	n/a	n/a
4	BCL3	chr21:46729788-46730361	GM12878	blood:	n/a	n/a
5	BHLHE40	chr21:46726878-46729243	HepG2	liver:	n/a	n/a
6	BHLHE40	chr21:46728969-46729214	K562	blood:	n/a	n/a
7	BHLHE40	chr21:46728735-46728749	K562	blood:	n/a	n/a
8	CBX3	chr21:46728979-46729306	K562	blood:	n/a	n/a
9	CEBPB	chr21:46728434-46728711	K562	blood:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
10	CEBPB	chr21:46728361-46728768	HepG2	liver:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
11	CEBPB	chr21:46728077-46729444	IMR90	lung:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
12	CEBPB	chr21:46728533-46728640	Hela-S3	cervix:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
13	CEBPB	chr21:46728387-46728714	HepG2	liver:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
14	CEBPB	chr21:46728286-46728798	HepG2	liver:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
15	CEBPB	chr21:46728374-46728764	HepG2	liver:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
16	CEBPB	chr21:46728365-46728838	A549	lung:	n/a	chr21:46728564-46728577 chr21:46728564-46728575
17	CEBPD	chr21:46728200-46728804	HepG2	liver:	n/a	n/a
18	CEBPD	chr21:46728378-46728748	HepG2	liver:	n/a	n/a
19	CHD2	chr21:46728503-46728770	HepG2	liver:	n/a	n/a
20	CHD2	chr21:46729077-46729137	K562	blood:	n/a	n/a
21	CTCF	chr21:46728687-46728826	GM10248	blood:	n/a	chr21:46728698-46728716
22	CTCF	chr21:46728691-46728779	MCF-7	breast:	n/a	chr21:46728698-46728716
23	CTCF	chr21:46729040-46729190	AG09309	skin:	n/a	n/a
24	CTCF	chr21:46729060-46729210	WI-38	lung:	n/a	n/a
25	CTCF	chr21:46728975-46729215	T-47D	breast:	n/a	n/a
26	CTCF	chr21:46729040-46729190	GM12873	blood:	n/a	n/a
27	CTCF	chr21:46729060-46729210	GM12865	blood:	n/a	n/a
28	CTCF	chr21:46729060-46729210	BJ	skin:	n/a	n/a
29	CTCF	chr21:46729021-46729238	MCF-7	breast:	n/a	n/a
30	CTCF	chr21:46728520-46728670	GM12872	blood:	n/a	n/a
31	CTCF	chr21:46729047-46729222	LNCaP	prostate:	n/a	n/a
32	CTCF	chr21:46728682-46728789	MCF-7	breast:	n/a	chr21:46728698-46728716
33	CTCF	chr21:46729005-46729248	GM19238	blood:	n/a	n/a
34	CTCF	chr21:46728698-46728774	LNCaP	prostate:	n/a	chr21:46728698-46728716
35	CTCF	chr21:46729020-46729170	RPTEC	kidney:	n/a	n/a
36	CTCF	chr21:46729060-46729210	K562	blood:	n/a	n/a
37	CTCF	chr21:46729040-46729190	NHDF-neo	bronchial:	n/a	n/a
38	CTCF	chr21:46728520-46728670	NHLF	lung:	n/a	n/a
39	CTCF	chr21:46728630-46728851	A549	lung:	n/a	chr21:46728698-46728716
40	CTCF	chr21:46729080-46729230	AG04449	skin:	n/a	n/a
41	CTCF	chr21:46728640-46728831	Gliobla	brain:	n/a	chr21:46728698-46728716
42	CTCF	chr21:46729060-46729210	GM12872	blood:	n/a	n/a
43	CTCF	chr21:46729008-46729228	HepG2	liver:	n/a	n/a
44	CTCF	chr21:46728511-46728882	HepG2	liver:	n/a	chr21:46728698-46728716
45	CTCF	chr21:46728660-46728810	GM12866	blood:	n/a	chr21:46728698-46728716
46	CTCF	chr21:46729040-46729190	HMF	breast:	n/a	n/a
47	CTCF	chr21:46729020-46729230	GM10266	blood:	n/a	n/a
48	CTCF	chr21:46729020-46729170	SAEC	small airway:	n/a	n/a
49	CTCF	chr21:46729000-46729150	Hela-S3	cervix:	n/a	n/a
50	CTCF	chr21:46729120-46729270	GM12866	blood:	n/a	n/a

No data

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:46728904..46729613-chr21:46859057..46859887,2	K562	blood:
2	chr21:46729693..46731540-chr21:46758328..46761233,2	K562	blood:
3	chr21:46723493..46725372-chr21:46725861..46728537,3	K562	blood:
4	chr21:46728354..46731184-chr21:46745278..46747549,4	MCF-7	breast:
5	chr21:46728395..46729331-chr21:46774690..46775582,2	MCF-7	breast:
6	chr21:46727532..46729794-chr21:46745790..46748227,2	MCF-7	breast:
7	chr21:46731341..46732996-chr21:46743188..46745694,2	K562	blood:
8	chr21:46560075..46560774-chr21:46729117..46729650,2	MCF-7	breast:
9	chr21:46728651..46729247-chr21:46737855..46738742,2	MCF-7	breast:
10	chr21:46727073..46730583-chr21:46829051..46833062,4	K562	blood:
11	chr21:46726238..46728769-chr21:46731285..46733297,3	K562	blood:
12	chr21:46710891..46712493-chr21:46728925..46730569,2	K562	blood:
13	chr21:46729928..46732032-chr21:46742592..46744160,2	MCF-7	breast:
14	chr21:46727455..46729208-chr21:46846804..46849388,2	MCF-7	breast:
15	chr1:112037699..112038220-chr21:46728893..46729413,2	MCF-7	breast:
16	chr21:46729832..46731625-chr21:46858347..46860225,2	MCF-7	breast:
17	chr21:46728697..46729644-chr21:46859033..46859869,3	MCF-7	breast:
18	chr21:46727309..46730446-chr21:46829894..46833293,4	K562	blood:
19	chr21:46729219..46730749-chr21:46743033..46744940,2	MCF-7	breast:
20	chr21:46726238..46728769-chr21:46731285..46733297,3	K562	blood:
21	chr21:46724975..46727680-chr21:46729685..46732102,2	MCF-7	breast:
22	chr21:46712235..46712971-chr21:46728288..46729510,5	MCF-7	breast:
23	chr21:46712772..46714291-chr21:46729064..46730988,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ADARB1-3	chr21:46730371-46730404	XLOC_013981

No data

Variant related genes	Relation type
LINC00315	TF binding region
ENSG00000224574	chromatin interactions
ENSG00000223768	chromatin interactions
ENSG00000184274	chromatin interactions

Extended variants
information (count: 203 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:203 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557307988	chr21:46727950-46727951	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs569282839	chr21:46727960-46727961	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs371808624	chr21:46727979-46727980	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs11306095	chr21:46727991-46727992	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs536662304	chr21:46727992-46727993	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs111798385	chr21:46727998-46727999	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs71334400	chr21:46728008-46728009	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs573701907	chr21:46728009-46728010	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs56008127	chr21:46728010-46728011	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs386819286	chr21:46728011-46728012	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs147066351	chr21:46728012-46728013	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs139190296	chr21:46728015-46728016	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs553238688	chr21:46728037-46728038	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs4819058	chr21:46728056-46728057	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs184831037	chr21:46728058-46728059	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs113513718	chr21:46728059-46728060	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs4819059	chr21:46728062-46728063	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs563593634	chr21:46728063-46728064	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs188423424	chr21:46728073-46728074	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs114095967	chr21:46728086-46728087	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs374975491	chr21:46728106-46728107	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs180745156	chr21:46728145-46728146	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs529408005	chr21:46728175-46728176	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs547566292	chr21:46728191-46728192	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs565958992	chr21:46728227-46728228	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs570932560	chr21:46728249-46728250	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs551623082	chr21:46728266-46728267	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs570261076	chr21:46728279-46728280	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs9977947	chr21:46728283-46728284	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs555110843	chr21:46728345-46728346	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs567340324	chr21:46728346-46728347	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs534448531	chr21:46728392-46728393	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs550187334	chr21:46728416-46728417	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs184980238	chr21:46728419-46728420	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs577880231	chr21:46728467-46728468	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs545236834	chr21:46728480-46728481	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs557248783	chr21:46728499-46728500	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs2838872	chr21:46728544-46728545	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs535741487	chr21:46728569-46728570	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs553742410	chr21:46728598-46728599	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs9789865	chr21:46728605-46728606	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs561972703	chr21:46728624-46728625	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs189395918	chr21:46728640-46728641	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs372756040	chr21:46728658-46728659	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs35969956	chr21:46728711-46728712	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs112605505	chr21:46728738-46728739	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs541095893	chr21:46728759-46728760	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs539217892	chr21:46728772-46728773	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs533308994	chr21:46728779-46728780	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs551561542	chr21:46728804-46728805	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	17426248	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	17237825	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD

Chromatin state (count:227 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:46713800-46738800	Weak transcription	Gastric	stomach
2	chr21:46715600-46730000	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr21:46715800-46730000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr21:46717600-46728200	Weak transcription	A549	lung
5	chr21:46719400-46728400	Enhancers	Fetal Muscle Trunk	muscle
6	chr21:46720600-46728000	Weak transcription	Stomach Mucosa	stomach
7	chr21:46721000-46728200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
8	chr21:46722800-46728600	Weak transcription	Fetal Thymus	thymus
9	chr21:46722800-46730200	Enhancers	Fetal Muscle Leg	muscle
10	chr21:46723000-46728000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr21:46723000-46730800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr21:46723400-46728000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr21:46724000-46728000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
14	chr21:46724200-46730200	Enhancers	Pancreas	Pancrea
15	chr21:46724800-46728600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
16	chr21:46724800-46728600	Enhancers	NH-A	brain
17	chr21:46725000-46728800	Weak transcription	Primary T helper cells PMA-I stimulated	--
18	chr21:46725000-46729600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr21:46725000-46730200	Enhancers	Fetal Lung	lung
20	chr21:46725400-46728000	Weak transcription	Primary T cells from cord blood	blood
21	chr21:46725600-46729000	Enhancers	Esophagus	oesophagus
22	chr21:46725800-46728800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
23	chr21:46725800-46730800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
24	chr21:46725800-46730800	Enhancers	Ovary	ovary
25	chr21:46726000-46728000	Weak transcription	Primary hematopoietic stem cells	blood
26	chr21:46726000-46729200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr21:46726200-46728200	Enhancers	Fetal Kidney	kidney
28	chr21:46726200-46728400	Enhancers	Breast Myoepithelial Primary Cells	Breast
29	chr21:46726200-46728800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr21:46726200-46729400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr21:46726200-46729600	Enhancers	Cortex derived primary cultured neurospheres	brain
32	chr21:46726200-46730200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr21:46726200-46730200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
34	chr21:46726200-46730200	Enhancers	Brain Substantia Nigra	brain
35	chr21:46726200-46730200	Bivalent Enhancer	Placenta	Placenta
36	chr21:46726200-46731400	Enhancers	Fetal Intestine Small	intestine
37	chr21:46726400-46728000	Enhancers	Adipose Nuclei	Adipose
38	chr21:46726400-46728000	Enhancers	Fetal Intestine Large	intestine
39	chr21:46726400-46728200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
40	chr21:46726400-46729200	Enhancers	Lung	lung
41	chr21:46726400-46730000	Enhancers	NHLF	lung
42	chr21:46726400-46730200	Enhancers	Liver	Liver
43	chr21:46726400-46730200	Enhancers	Left Ventricle	heart
44	chr21:46726400-46730200	Enhancers	Right Atrium	heart
45	chr21:46726400-46730400	Enhancers	Right Ventricle	heart
46	chr21:46726600-46728600	Enhancers	Fetal Heart	heart
47	chr21:46726600-46728800	Flanking Active TSS	HepG2	liver
48	chr21:46726600-46729000	Enhancers	Rectal Mucosa Donor 31	rectum
49	chr21:46726600-46729800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr21:46726600-46730000	Enhancers	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links